Dyssomnia

Research Shows Pycnogenol® French Maritime Pine Bark Extract Is a Key Natural Supplement to Support Women's Health Throughout Life

Retrieved on: 
Wednesday, May 11, 2022
Menopause, National Women's Health Network, Urinary tract infection, Woman, Collagen, Dysmenorrhea, Safety, Research, Cognition, Dietary supplement, Patient, Infection, Frost, Blood, Review, Malcolm Baldrige National Quality Award, Risk, Overalls, Anxiety, Dyssomnia, Skin, Homocysteine, Health, Nervous, Science, Memory, Joint, Life, Goal, Hyaluronic acid, Multimedia, Birth control, Condensed tannin

HOBOKEN, N.J., May 11, 2022 /PRNewswire/ -- Women's health goals and concerns evolve and change with age. In observance of National Women's Health Month during May, experts are highlighting Pycnogenol® French maritime pine bark extract as a leading supplement for women's health throughout life. The super antioxidant is supported by a vast catalog of research demonstrating its widespread benefits for supporting skin, cognitive and joint health and managing menstrual pain, UTIs and menopause.

Key Points: 
  • In observance of National Women's Health Month during May, experts are highlighting Pycnogenol French maritime pine bark extract as a leading supplement for women's health throughout life.
  • "Women's Health Month is a time for women to make their health and well-being a top priority.
  • Pycnogenol French maritime pine bark extract is a proven, unique, standardized blend of powerful natural antioxidants.
  • Horphag Research is the exclusive worldwide distributor for Pycnogenol (pic-noj-en-all) brand French maritime pine bark extract.

Insights on the Sleep Aids Global Market to 2025 - Technological Advancements Present Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 2, 2020
Health, Pharmaceutical, Sleep disorders, Sleep, Branches of biology, Mind, Insomnia, Sleep medicine, Dyssomnia

The rise in the incidences of sleeping disorders such as insomnia, sleep apnea, and restless leg syndrome is the major driver for the global sleep aids market.

Key Points: 
  • The rise in the incidences of sleeping disorders such as insomnia, sleep apnea, and restless leg syndrome is the major driver for the global sleep aids market.
  • The US is the leading country in terms of sales in the global sleep aids market followed by Germany and the UK.
  • Based on the geographical regions, North America generated the highest revenue in the global sleep aids market.
  • The improving healthcare sector in the developing nations in the Asia Pacific is offering favorable business opportunities to the major players in the sleep aids market.

Global Sleep Aids Market: Consumer Behavior Analysis by Countries, Buying Pattern Analysis, Demographics, Trends Analysis, Survey Findings and Results, Leading Companies and Their Market Strategies

Retrieved on: 
Wednesday, July 8, 2020
Sleep disorders, Branches of biology, Organ systems, Insomnia, Sleep apnea, Sleep, Dyssomnia, Sleep sex

The study also provides insights into the factors affecting the buying decisions, consumer preferences, and the demographic factors promoting the growth of the products of the global sleep aids market.

Key Points: 
  • The study also provides insights into the factors affecting the buying decisions, consumer preferences, and the demographic factors promoting the growth of the products of the global sleep aids market.
  • Sleep aids help in the diagnosis as well as the treatment of sleeping disorders such as insomnia, sleep apnea, restless leg syndrome, and others.
  • The rise in the incidences of sleeping disorders such as insomnia, sleep apnea, and restless leg syndrome is the major driver for the global sleep aids market.
  • The US is the leading country in terms of sales in the global sleep aids market followed by Germany and the UK.